PharmTech Europe, Weekly Alert
Having trouble viewing this e-mail? CLICK HERE

PharmTech Europe
22 January 2020

PHARMTECH.COM

CURRENT ISSUE

SUBSCRIBE

FORWARD

twitter twitter
advertisement

TOP STORIES

Bosch Packaging Technology Becomes Syntegon Technology After Successful Transaction

The renaming comes after the sale of Bosch Packaging Technology to CVC Capital Partners was completed on Jan. 2, 2020.
/ read more /


UK Government, Novartis Collaborate on Clinical Trial for New Cholesterol Treatment

The UK government announced it will be collaborating with Novartis on the launch of a clinical trial for the company’s new cholesterol treatment, Inclisiran.
/ read more /


advertisement



Industry News

UK Holds Appeal for Cell and Gene Therapy Clinical Trials, According to Latest Data

The Cell and Gene Therapy Catapult (CGT Catapult) has revealed that the United Kingdom is a favourable environment for cell and gene therapy clinical trials..
/ read more /


CPhI and AAPS Partner to Expand Scientific Content

The companies will kick off their partnership with CPhI North America, a conference that hosts the North American pharmaceutical supply chain.
/ read more /


More Industry News

Subscribe

Subscribers can enjoy each full issue of Pharm Tech Europe in print, or via Pharm Tech Europe apps.

subscription offers
subscribe
advertisement

Regulatory News

Inflazome to be Granted Patents in US and Europe

Inflazome, a biotech company based in Dublin, Ireland, has announced that the United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO) will grant its patent applications in January 2020.
/ read more /


FDA Approves Merck & Co’s Keytruda for High-Risk, Non-Muscle Invasive Bladder Cancer

The approval was based on successful data from a years-long trial that assessed patient’s tumor status every 12 or 24 weeks for up to 24 months.
/ read more /


More Regulatory News

Bio/Pharma News

Horizon Discovery, Mammoth Biosciences Sign Collaboration and License Agreement

Horizon Discovery Group and Mammoth Biosciences have signed a collaboration and license agreement aimed at the development of the next generation of engineered Chinese hamster ovary (CHO) cell lines to improve biotherapeutics production.
/ read more /



ProBioGen, Lava Therapeutics Close Development and Manufacturing Agreement

ProBioGen and Lava Therapeutics have closed the cell line development and manufacturing agreement for Lava’s novel bispecific antibody lead candidate.
/ read more /


More Bio/Pharma News

Supplier News

Catalent Launches Direct-to-Patient Clinical Supply Services

Catalent’s FlexDirect service offers sponsors multiple delivery options from a single inventory.
/ read more /



PhoreMost, Boehringer Ingelheim Collaborate on Multi-Project Drug Discovery

PhoreMost, a biopharma company based in the United Kingdom, and Boehringer Ingelheim have entered into a multi-project drug discovery collaboration agreement.
/ read more /


More Supplier News

FEATURED TOPICS

QUALITY ASSURANCE/QUALITY CONTROL

Applying Lessons Learned from the Semiconductor Industry

Applying lessons of raw materials’ characterization and supply-chain control from the semiconductor industry allow more rigorous control of the biopharmaceutical manufacturing process.
/ read more /

 

PROCESS DEVELOPMENT

DOE Gains Ground in Biopharmaceutical Development

As equipment evolves and use of PAT increases, DOE is becoming an integral part of upstream bioprocess development.
/ read more /

QUALITY SYSTEMS

Investigating Combination Product Failures

Investigating deviations of combination products needs to accommodate both the drug and device components, says Susan J. Schniepp, executive vice-president of post-approval pharma and distinguished fellow, Regulatory Compliance Associates.
/ read more /

VIEWPOINT

Fighting the Good Fight

Nearly four decades after the first diagnosis, the fight to treat HIV/AIDs continues.
/ read more /


PRODUCT PROFILE

Catalent

Catalent Unveils New European Product Launch Site
Catalent’s site in Anagni, Italy offers extensive capabilities in aseptic liquid and powder filling, as well as comprehensive packaging solutions to support product launches for oral solids, sterile, and biologics products.
/ read more /

Stoelzle Glass Group

Safe Packaging for Healthy Products
Pharma bottles are an integrated part of the final medicine. That’s why Stoelzle cares that much about quality and reliability when manufacturing safe packaging for healthy products in soda lime Type III quality.
/ read more /

Events

SMi’s 9th Annual Pharmaceutical Microbiology Conference

London, UK

20-21 January 2020

Pharmapack

Paris, France

5–6 February 2020

SMI Group's 3rd Annual Injectable Drug Delivery Conference

London, UK

13–14 May 2020

more events

eBOOKS

Regulatory Sourcebook and Reference, September 2019

Pharmaceutical Technology’s Regulatory Sourcebook and Reference highlights regulatory trends and enforcement actions, risk-based studies for analytical procedure validation, and generic drug applications, as well as a detailed analysis of pharmacopoeia requirements, challenges with compliance.

contribute | CONTACT EDITORS | CONTACT SALES | subscribe | advertise